Lorenzo Tallarigo's Net Worth
$58.8 Million
Who is Lorenzo Tallarigo?
Lorenzo Tallarigo has an estimated net worth of $58.8 Million. This is based on reported shares across multiple companies, which include LILLY ELI & CO, and INTERCEPT PHARMACEUTICALS INC.
SEC CIK
Lorenzo Tallarigo's CIK is 0001276039
Past Insider Trading and Trends
2005 was Lorenzo Tallarigo's most active year for acquiring shares with 8 total transactions. Lorenzo Tallarigo's most active month to acquire stocks was the month of January. 2005 was Lorenzo Tallarigo's most active year for disposing of shares, totalling 13 transactions. Lorenzo Tallarigo's most active month to dispose stocks was the month of January. 2008 saw Lorenzo Tallarigo paying a total of $1,192,897.40 for 23,510 shares, this is the most they've acquired in one year. In 2008 Lorenzo Tallarigo cashed out on 27,951 shares for a total of $1,424,590.36, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
LILLY ELI & CO (LLY) Snapshot price: $900.9999
President, Internat'l Opers.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.97% | -9.60K |
$50.29 | -$482,985.16 | 64.46K |
Mar 31
| |||
Form 4
| -2.68% | -2.04K |
$49.84 | -$101,823.12 | 74.06K |
Mar 24
| |||
Form 4
| -11.61% | -10.00K |
$51.50 | -$515,000.00 | 76.11K |
Feb 26
| |||
Form 4
| -6.82% | -6.30K |
$51.52 | -$324,782.08 | 86.11K |
Feb 1
| |||
Form 4
| +34.12% | 23.51K |
$50.74 | $1,192,897.40 | 92.41K |
Jan 25
| |||
Form 4
| -2.31% | -1.63K |
$52.79 | -$85,836.54 | 68.9K |
Nov 30
| |||
Form 4
| -6.04% | -4.53K |
$57.73 | -$261,706.76 | 70.53K |
Scheduled
|
Sep 4
| ||
Form 4
| -5.70% | -4.53K |
$58.73 | -$266,223.09 | 75.06K |
Scheduled
|
Jun 1
| ||
Form 4
| -5.39% | -4.53K |
$55.00 | -$249,315.00 | 79.59K |
Scheduled
|
Apr 4
| ||
Form 4
| -4.77% | -4.21K |
$54.12 | -$228,061.68 | 84.12K |
Feb 1
| |||
Form 4
| +29.31% | 20.02K |
$52.86 | $1,058,521.50 | 88.34K |
Jan 17
| |||
Form 4
| -7.84% | -5.81K |
$56.96 | -$331,161.72 | 68.31K |
Oct 20
| |||
Form 4
| +12.10% | 8K |
$34.60 | $276,760.00 | 74.13K |
Oct 4
| |||
Form 4
| -2.28% | -1.54K |
$54.88 | -$84,679.84 | 66.13K |
Jul 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| -2.56% | -1.78K |
$56.62 | -$100,840.22 | 67.67K |
Feb 1
| |||
Form 4
| +24.08% | 13.48K |
$57.04 | $768,785.12 | 69.45K |
Jan 20
| |||
Form 4
| -2.68% | -1.54K |
$50.50 | -$77,921.50 | 55.97K |
Dec 1
| |||
Form 4
| +1.41% | 801 |
$39.56 | -$19,981.29 | 57.52K |
Scheduled
|
Jul 1
| ||
Form 4
| +1.48% | 826 |
$40.85 | -$21,629.20 | 56.72K |
Scheduled
|
Jun 1
| ||
Form 4
| +1.51% | 829 |
$40.94 | -$21,653.37 | 55.89K |
Scheduled
|
May 2
| ||
Form 4
| +1.40% | 761 |
$37.76 | -$17,736.90 | 55.06K |
Scheduled
|
Apr 1
| ||
Form 4
| -3.55% | -2.00K |
$39.48 | -$175,345.00 | 54.3K |
Scheduled
|
Feb 3 - Mar 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
| +3.68% | 2K |
$23.41 | $46,815.00 | 56.3K |
Feb 3
| |||
Form 4
| +11.50% | 5.6K |
$56.79 | $318,024.00 | 54.3K |
Jan 14
| |||
Form 4
| +44.51% | 15K |
—
|
—
| 48.7K |
Dec 20
| |||
Form 4
| +55.30% | 12K |
$14.66 | $175,890.00 | 33.7K |
Oct 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTERCEPT PHARMACEUTICALS INC (ICPT) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$126.44 | -$466,465.40 |
0
|
Scheduled
|
Jul 7
| ||
Form 4
| -100.00% | -1.64K |
$254.68 | -$511,152.00 |
0
|
Scheduled
|
May 7 - May 9
| ||
Form 4
| +8.69% | 516.06K |
$164.05 | -$101,982,843.53 | 6.45M |
Apr 9 - Apr 10
| |||
Form 4
|
—
|
0
|
$354.52 | -$130,463.36 | 1.64K |
Scheduled
|
Feb 9 - Feb 10
| ||
Form 4
| -52.86% | -1.84K |
$67.41 | -$123,966.99 | 1.64K |
Scheduled
|
Jan 7
| ||
Form 4
| +11.83% | 368 |
—
|
—
| 3.48K |
Nov 9
| |||
Form 4
| -2.06% | -124.91K |
$62.50 | -$7,807,000.00 | 5.94M |
Oct 21
| |||
Form 4
| -15.63% | -1.12M |
$62.50 | -$70,213,437.50 | 6.06M |
Oct 15
| |||
Form 4
| +89.70% | 1.47K |
—
|
—
| 3.11K |
Oct 10
| |||
Form 4
|
∞
| 1.64K |
—
|
—
| 1.64K |
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16
| |||
Form 4
| +349.00% | 5.59M |
—
|
—
| 7.19M |
Jul 31 - Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||